OR WAIT null SECS
Editor-in-chief Tina Q. Tan, MD, FAAP, FIDSA, FPIDS reflects on what 2022 may hold and shares her must-read articles from the January/February issue.
It is hard to believe that 2022 (Chinese zodiac Year of the Tiger) has started. We begin the year, unfortunately, with COVID-19 still front and center of health care news. The Omicron variant has, as of this writing, spread to more than 110 countries, including here in the United States. This variant contains 30 mutations in the spike protein, which makes it highly transmissible and has been noted to be the most rapidly spreading of all the SARS-CoV-2 variants. The current COVID-19 vaccines provide some protection against this variant, although less than against the other variants. The risk for breakthrough infections and hospitalizations among those that are fully vaccinated is increased with the Omicron variant.
On a more promising note, ever since the US Food and Drug Administration granted emergency use authorization for the Pfizer/BioNTech vaccine for children aged 5 to 11 years, an estimated 20% of those in this age group (as of this writing) have received at least 1 dose of the vaccine. Let’s hope this trend continues.
This month’s January/February issue packs a number of must-read articles:
Thank you for providing outstanding care to your patients during these rapidly changing times. “Wishing you a Happy New Year! May it be filled with new adventures and good fortunes.” (Anonymous.)
Please stay safe and well. As always, I welcome your suggestions, comments, and questions.
With warm regards,
Tina Q. Tan